 UNIONDALE, N.Y., Oct. 18, 2021 GLOBE NEWSWIRE -- Angion Biomedica Corp NASDAQ:ANGN, a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases, today announced it will be presenting four posters at the American Society of Nephrologys Kidney Week 2021 virtual meeting to be held November 4-7, 2021. 